VANCOUVER, BC — STEMCELL Technologies, Canada’s largest biotechnology company, is marking its 30th year of accelerating research into cancer and other diseases by celebrating its culture of collaboration, curiosity, and discovery…. Read More
First site in Health Care business to achieve carbon neutrality in Scope 1 and 2 emissions Switch to biogas from local supplier Goal of carbon neutrality in Scope 1 and… Read More
Health technology assessment (HTA) agencies reinforce the therapeutic value of PLUVICTO™ and need for new approaches to treat advanced prostate cancer Positive HTA recommendations for reimbursement are an important milestone… Read More
LAVAL, QC — Bausch Health Companies Inc. (NYSE/TSX: BHC) and KKR today announced that Bausch Receivables Funding LP, an Ontario limited partnership and wholly-owned subsidiary of Bausch Health, has entered… Read More
Oral Health Care Companies Celebrate the 100th ADHA Conference by Highlighting New Data for the Treatment of Periodontal Disease LAVAL, QC — Bausch Health Companies Inc. (NYSE/TSX: BHC) and its oral… Read More
